Wearable sweat biosensors enable the non-invasive, real-time monitoring of hormones. Here, we highlight the development and commercialization of a wearable technology that can measure hormone ...

Biosensors are devices used to detect the presence or concentration of a biological analyte, such as a biomolecule, a biological structure or a microorganism. Biosensors consist of three parts: a ...

QLS-111 added to latanoprost drove up to 3.6 mmHg greater reduction in IOP as compared to latanoprost alone DEDHAM, Mass., February 05, 2025--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage ...

The drug in question, dubbed QLS‑111, has been created with Qlaris’ ATP-sensitive potassium channel modulator platform and is designed to lower intraocular pressure (IOP). The results ...

QLS-111 added to latanoprost drove up to 3.6 mmHg greater reduction in IOP as compared to latanoprost alone DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company ...

If implemented, this technology could buttress the operation of sensors and navigation systems, extend detection range, and greatly enhance computing power. But the real trick will be putting ...

Have you ever wondered how speed guns measure the speed of moving vehicles or how an athlete's sprint speed is recorded? Normally these speed sensors work with radar or laser technology to bounce back ...

Lockheed Martin has been awarded a $270 million contract by the US Air Force to integrate next-generation infrared defensive sensors on the F-22 Raptor. Under the agreement, the F-22 will be equipped ...

QLS-31905 is under clinical development by Qilu Pharmaceutical and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I drugs for Pancreatic Cancer have a 74% phase transition ...

QLS-111 is under clinical development by Qlaris Bio and currently in Phase II for Open-Angle Glaucoma. According to GlobalData, Phase II drugs for Open-Angle Glaucoma have a 39% phase transition ...